1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Warning Letters

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
  • Frequently requested records may be accessed on the Reading Room page.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Rama Food Manufacture Corp. Human Foods Program CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated/L. monocytogenes
Best Chinese Medicines LLC Center for Drug Evaluation and Research (CDER) Unapproved New Drugs
Northland Nuclear Medicine, LLC Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
TSP Solutions Pte. Ltd. Center for Drug Evaluation and Research (CDER) Request for Records/CGMP/Finished Pharmaceuticals/Adulterated
Sanrace Biotechnology Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Chirp Innovations, LLC Center for Devices and Radiological Health CGMP/QSR/Medical Devices/Adulterated
Pro-Optics, LLC Center for Devices and Radiological Health Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)
Peter Schiff Enterprises Center for Devices and Radiological Health Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)
Beaute Bounty Center for Biologics Evaluation and Research (CBER) Unapproved New Drugs/Unlicensed Biological Product Violations
Calibrate IV Hydration Center for Biologics Evaluation and Research (CBER) Unapproved New Drugs/Unlicensed Biological Product Violations

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.
Back to Top